Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer a 5-year prospective, randomized, controlled study

Archives of Internal Medicine

Volumn 163, Issue 17, 2003, Pages 2020-2024

  Liu, Chen Chiung ^a   Lee, Chia Long ^a,b   Chan, Chung Chuan ^a   Tu, Tien Chien ^a   Liao, Chien Chung ^a   Wu, Chi Hwa ^a   Chen, Tzen Kwan ^a  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; BISMUTH CITRATE; CLARITHROMYCIN; FAMOTIDINE; METRONIDAZOLE; OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RANITIDINE; TINIDAZOLE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOSCOPY; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER PYLORI; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT INDICATION; UREA BREATH TEST;

ADULT; AGED; ANTACIDS; ANTI-ULCER AGENTS; BREATH TESTS; CARBOLINES; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; FAMOTIDINE; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; ORGANOMETALLIC COMPOUNDS; PEPTIC ULCER HEMORRHAGE; PROSPECTIVE STUDIES; RECURRENCE; TREATMENT OUTCOME;

EID: 0141676725     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.17.2020     Document Type: Article

References (29)

1. Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med. 1994;331:717-727.
2. Vreeburg EM, Snel P, de Bruijne JW, Bartelsman JF, Rauws EA, Tytgat GNJ. Acute upper gastrointestinal bleeding in the Amsterdam area: incidence, diagnosis, and clinical outcome. Am J Gastroenterol. 1997;92:236-243.
3. Rockall TA, Logan RF, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal hemorrhage. Gut. 1996;38:316-321.
4. Brullet E, Campo R, Calvet X, Coroleu D, Rivero E, Simo DJ. Factors related to the failure of endoscopic injection therapy for bleeding gastric ulcer. Gut. 1996; 39:155-158.
5. Tomita T, Fukuda Y, Tamura K, et al. Successful eradication of Helicobacter pylori prevents relapse of peptic ulcer disease. Aliment Pharmacol Ther. 2002;16 (suppl 2):204-209.
6. Laine L, Hopkins RJ, Girardi LS. Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? a meta-analysis of rigorously designed trials. Am J Gastroenterol. 1998;93:1409-1415.
7. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology. 1996;110:1244-1252.
8. Van der Hulst RW, Rauws EA, Koycu B, et al. Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study. Gastroenterology. 1997;113:1082-1086.
9. Dronfield MW. Upper gastrointestinal bleeding. In: Misiewicz JJ, Pounder RE, Venables CW, eds. Diseases of the Gut and Pancreas. 2nd ed. London, England: Blackwell; 1994:367-380.
10. Riemann JF, Schilling D, Schauwecker P, et al. Cure with omeprazole plus amoxicillin versus long-term ranitidine therapy in Helicobacter pylori-associated peptic ulcer bleeding. Gastrointest Endosc. 1997;46:299-304.
11. Rockall TA, Logan RF, Devlin HB, Northfield TC, for the Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. Incidence of and mortality from acute gastrointestinal haemorrhage in the United Kingdom. BMJ. 1995;311:222-226.
12. Jensen DM. Heat probe for haemostasis of bleeding peptic ulcers: techniques and results of a randomized controlled trial. Gastrointest Endosc. 1990;36(suppl): S42-S49.
13. Matthewson K, Swain CP, Bland M, Kirkham JS, Bown SG, Northfield TC. Randomized comparison of ND: YAG laser, heat probe, and no endoscopic therapy for bleeding peptic ulcer. Gastroenterology. 1990;98:1239-1244.
14. Laine L. Multipolar peptic ulcers: electrocoagulation in the treatment of active upper gastrointestinal haemorrhage: a prospective controlled trial. N Engl J Med. 1987;316:1613-1617.
15. Fisher L, Robraek-Madsen M, Thomson H, Host V, Wara P. Peptic ulcer hemorrhage: factors predisposing to recurrence. Scand J Gastroenterol. 1994;29:414-418.
16. Miller JP, Faragher EB. Relapse of duodenal ulcer: does it matter which drug is used in initial treatment? Br Med J (Clin Res Ed). 1986;293:1117-1118.
17. Martin DF, Hollanders D, May SI, et al. Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate. Lancet. 1981;1:7-10.
18. McNulty CA, Dent J, Wise R. Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents. Antimicrob Agents Chemother. 1985;28: 837-838.
19. Howden CW. Clinical expression of Helicobacter pylori infection. Am J Med. 1996; 100(suppl 1):27S-34S.
20. Peura DA. The report of the Digestive Health Initiative International Update Conference on Helicobacter pylori. Gastroenterology. 1997;113(suppl 1):S4-S8.
21. Graham DY, Hepps KS, Ramirez FC, Lew GM, Saeed ZA. Treatment of Helicobacter pylori reduces the rates of rebleeding in peptic ulcer disease. Scand J Gastroenterol. 1993;28:939-942.
22. Rokkas T, Karameris A, Mavrogeorgis A, Rallis E, Giannikos N. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc. 1995;41:1-4.
23. Macri G, Milani S, Surrenti E, Passaleva MT, Salvadori G, Surrenti C. Eradication of Helicobacter pylori reduces the rate of duodenal ulcer rebleeding: a long-tem follow-up study. Am J Gastroenterol. 1998;93:925-927.
24. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht 2000 Consensus report. Aliment Pharmacol Ther. 2002;16:167-180.
25. National Institutes of Health Consensus Development Conference. Helicobacter pylori in peptic ulcer disease. JAMA. 1994;272:65-69.
26. Lai KC, Hui WM, Wong WM, et al. Treatment of Helicobacter pylori in patients with duodenal ulcer hemorrhage: a long-term randomized, controlled study. Am J Gastroenterol. 2000;95:2225-2232.
27. Labenz J, Borsch G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion. 1994;55:19-23.
28. Lee CL, Tu TC, Wu CH, et al. One-week low-dose triple therapy is effective in treating Helicobacter pylori-infected patients with bleeding peptic ulcers. J Formos Med Assoc. 1998;97:733-737.
29. Teh BH, Lin JT, Pan WH, et al. Seroprevalence and associated risk factors of Helicobacter pylori infection in Taiwan. Anticancer Res. 1994;14:1389-1392.